je.st
news
Joel Marcus of Alexandria Real Estate on the Biotech Boom
2015-03-30 22:39:56| Biotech - Topix.net
Biopharmaceutical venture capital investment climbed from $4.52 billion in 2013 to $5.29 billion in 2014, a 17% increase, according to Dow Jones VentureSource. Joel Marcus, chief executive of Alexandria Real Estate Equities Inc ., has been in biotech since its early days.
Tags: real
estate
real estate
boom
Category:Biotechnology and Pharmaceuticals